StockData
Tenax Therapeutics, Inc. logo

Tenax Therapeutics, Inc. (TENX) stock

TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.39−0.04 (-2.80%)

Close on Nov 19, 2026Market cap $52.02MP/E –Yield –

Tenax Therapeutics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Tenax Therapeutics's free cash flow for the twelve months ending Jun 30, 2023 was -$7.67M. For fiscal 2022 it was -$11.39M. The highest annual figure on record is -$4.94M in fiscal 2013.

Annual free cash flow

PeriodPeriod endValueChange
FY2022Dec 31, 2022-$11.39M–
FY2021Dec 31, 2021-$10.86M–
FY2020Dec 31, 2020-$9.28M–
FY2019Dec 31, 2019-$7.56M–
FY2018Dec 31, 2018-$5.51M–
FY2017Dec 31, 2017-$12.15M–
FY2015Apr 30, 2015-$9.75M–
FY2014Apr 30, 2014-$9.27M–
FY2013Apr 30, 2013-$4.94M–
FY2012Apr 30, 2012-$8.30M–
FY2011Apr 30, 2011-$8.64M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2023CQ2 2023Jun 30, 2023-$924.57K–
Q1 FY2023CQ1 2023Mar 31, 2023-$1.73M–
Q4 FY2022CQ4 2022Dec 31, 2022-$1.68M–
Q3 FY2022CQ3 2022Sep 30, 2022-$3.33M–
Q2 FY2022CQ2 2022Jun 30, 2022-$3.43M–
Q1 FY2022CQ1 2022Mar 31, 2022-$2.94M–
Q4 FY2021CQ4 2021Dec 31, 2021-$2.77M–
Q3 FY2021CQ3 2021Sep 30, 2021-$3.02M–
Q2 FY2021CQ2 2021Jun 30, 2021-$1.85M–
Q1 FY2021CQ1 2021Mar 31, 2021-$3.22M–
Q4 FY2020CQ4 2020Dec 31, 2020-$1.99M–
Q3 FY2020CQ3 2020Sep 30, 2020-$2.39M–
Q2 FY2020CQ2 2020Jun 30, 2020-$2.23M–
Q1 FY2020CQ1 2020Mar 31, 2020-$2.67M–
Q4 FY2019CQ4 2019Dec 31, 2019-$1.73M–
Q3 FY2019CQ3 2019Sep 30, 2019-$1.78M–
Q2 FY2019CQ2 2019Jun 30, 2019-$1.91M–
Q1 FY2019CQ1 2019Mar 31, 2019-$2.14M–
Q4 FY2018CQ4 2018Dec 31, 2018-$1.20M–
Q3 FY2018CQ3 2018Sep 30, 2018-$1.56M–
Q2 FY2018CQ2 2018Jun 30, 2018-$1.19M–
Q1 FY2018CQ1 2018Mar 31, 2018-$1.56M–
Q4 FY2017CQ4 2017Dec 31, 2017-$1.28M–
Q3 FY2017CQ3 2017Sep 30, 2017-$1.23M–
Q2 FY2017CQ2 2017Jun 30, 2017-$5.60M–
Q1 FY2017CQ1 2017Mar 31, 2017-$4.04M–
Q4 FY2015CQ1 2015Apr 30, 2015-$1.63M–
Q3 FY2015CQ4 2014Jan 31, 2015-$3.23M–

More Tenax Therapeutics figures

See a number that looks wrong?